UPDATE: JPMorgan Starts HilleVax, Inc. (HLVX) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
UPDATE: Stifel Starts HilleVax, Inc. (HLVX) at Buy
May 24, 2022 3:36 AM EDT(Updated - May 24, 2022 5:16 AM EDT)
Stifel analyst Stephen Willey initiates coverage on HilleVax, Inc. (NASDAQ: HLVX) with a Buy rating and a price target of $34.00.
The analyst comments "We believe the burden of disease and direct/indirect healthcare costs associated with norovirus-caused AGE which disproportionately impacts young children (... More
